Sort
21,453 grants matching “tuberculosis”
Emerging XDR-TB: Host and Pathogen Contributions
$585,448Gilla Kaplan · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · AI
Biology and Biosignatures of Anti-Tuberculosis Treatment Response
$585,300John T Belisle · Colorado State University · U01 · FY2017 · AI
Infectious Disease/Basic Microbial Pathogenic Mechanisms
$585,190Daniel E Goldberg · Washington University · T32 · FY2022 · AI
Research Program and Administrative Center
$585,162Judith E.n. Albino · University Of Colorado Denver · U54 · FY2008 · DE
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
$585,157Volker Briken · Univ Of Maryland, College Park · R01 · FY2023 · AI
Project 2 Bacterial determinants of host adaptation and evolutionary success
$585,147Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI
IGF::OT::IGF ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
$585,077Rocco Casagrande · Gryphon Scientific, Llc · N01 · FY2016 · AI
Mechanisms and regulation of Mycobacterium tuberculosis iron acquisition
$584,781Issar Smith · Univ Of Med/Dent Of Nj-Nj Medical School · R56 · FY2009 · AI
Bacterial Determinants of TB Progression
$584,671David R Sherman · Seattle Biomedical Research Institute · U19 · FY2013 · AI
Data Coordinating Center for Systems Biology Approach to the Mechanisms of TB
$584,652Kathleen F. Kerr · University Of Washington · R01 · FY2012 · HL
Project 2: Response to Treatment
$584,650David R Sherman · Seattle Children'S Hospital · U19 · FY2021 · AI
The Effectiveness and Cost-Effectiveness of Implementing Evidence-Based Depression Treatment within the TB Care Platform in South Africa: A Hybrid Effectiveness-Implementation Trial
$584,552Annika Claire Sweetland · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2022 · AI
TB Vaccine Candidates Found in Patients' Bodily Fluids and Murine MHC-1 Molecule
$584,485Antonio Campos-Neto · Ada Forsyth Institute, Inc. · R01 · FY2010 · AI
Multi-level and Intersectional Stigma and other Social Determinant Effects on TB Case Detection, Care, and Treatment Outcomes: The MISSED TB Outcomes Study
$584,233Andrew Medina-Marino · Desmond Tutu Hiv Foundation · R01 · FY2025 · AI
Beta-lactamase fluorescent probes for bacterial detection
$584,232Jianghong Rao · Stanford University · R01 · FY2019 · AI
Beta-lactamase fluorescent probes for bacterial detection
$584,232Jianghong Rao · Stanford University · R01 · FY2018 · AI
Beta-lactamase fluorescent probes for bacterial detection
$584,232Jianghong Rao · Stanford University · R01 · FY2017 · AI
Host-Pathogen Determinants of M.tb Latency
$584,168Gilla Kaplan · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · AI
Efficacy and cost of HAART DOT in methadone clinics
$584,081Julia H. Arnsten · Albert Einstein College Of Medicine · R01 · FY2007 · DA
Antimicrobial Resistant Bacteria: Exposures and Health of Cattle Workers
$583,992Joshua William Schaeffer · Colorado State University · R01 · FY2020 · OH
Interplay of Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial Pathogens
$583,867David P. Giedroc · Trustees Of Indiana University · R35 · FY2018 · GM
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$583,781Patrick S. Stayton · University Of Washington · R01 · FY2021 · AI
Interplay of Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial Pathogens
$583,775David P. Giedroc · Trustees Of Indiana University · R35 · FY2017 · GM
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa
$583,702Max O'Donnell · Columbia University Health Sciences · R01 · FY2023 · AI
Interplay of Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial Pathogens
$583,480David P. Giedroc · Trustees Of Indiana University · R35 · FY2019 · GM